From among them, serum miR-24, miR-23a and miR-145 were found to be significantly down-regulated in AMI+AKI+ patients and showed good discriminatory power (i.e., better than serum NGAL) in detecting in post-AMI AKI within 24 h of admission. This evidence concerns the gene LCN2 and acute kidney injury.